{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:20:08Z","timestamp":1772479208547,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,2]]},"DOI":"10.7759\/cureus.104553","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T18:20:12Z","timestamp":1772475612000},"source":"Crossref","is-referenced-by-count":0,"title":["Characterization of Antinuclear, Myositis-Specific, and Myositis-Associated Antibodies in a Large Sample of Patients With Idiopathic Inflammatory Myopathies"],"prefix":"10.7759","author":[{"given":"Rafaella A","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel K","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg IE","year":"2021","unstructured":"Lundberg IE, Fujimoto M, Vencovsky J, et al.. Idiopathic inflammatory myopathies. Nat Rev Dis Primers. 2021, 7:86. 10.1038\/s41572-021-00321-x","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2013(07)04","article-title":"Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis","volume":"68","author":"Cruellas MG","year":"2013","unstructured":"Cruellas MG, Viana Vdos S, Levy-Neto M, Souza FH, Shinjo SK. Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics (Sao Paulo). 2013, 68:909-14. 10.6061\/clinics\/2013(07)04","journal-title":"Clinics (Sao Paulo)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acc.2024.04.001","article-title":"Autoantibody evaluation in idiopathic inflammatory myopathies","volume":"120","author":"Tebo AE","year":"2024","unstructured":"Tebo AE. Autoantibody evaluation in idiopathic inflammatory myopathies. Adv Clin Chem. 2024, 120:45-67. 10.1016\/bs.acc.2024.04.001","journal-title":"Adv Clin Chem"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis","volume":"280","author":"Betteridge Z","year":"2016","unstructured":"Betteridge Z, McHugh N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med. 2016, 280:8-23. 10.1111\/joim.12451","journal-title":"J Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103608","article-title":"Reflecting on a decade of the international consensus on ANA patterns (ICAP): accomplishments and challenges from the perspective of the 7th ICAP workshop","volume":"23","author":"Andrade LE","year":"2024","unstructured":"Andrade LE, Klotz W, Herold M, et al.. Reflecting on a decade of the international consensus on ANA patterns (ICAP): accomplishments and challenges from the perspective of the 7th ICAP workshop. Autoimmun Rev. 2024, 23:103608. 10.1016\/j.autrev.2024.103608","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-022-00266-z","article-title":"VI Brazilian consensus guidelines for detection of anti-cell autoantibodies on HEp-2 cells","volume":"62","author":"Cruvinel WM","year":"2022","unstructured":"Cruvinel WM, Andrade LE, Dellavance A, et al.. VI Brazilian consensus guidelines for detection of anti-cell autoantibodies on HEp-2 cells. Adv Rheumatol. 2022, 62:34. 10.1186\/s42358-022-00266-z","journal-title":"Adv Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214436","article-title":"Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective","volume":"78","author":"Damoiseaux J","year":"2019","unstructured":"Damoiseaux J, Andrade LE, Carballo OG, et al.. Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective. Ann Rheum Dis. 2019, 78:879-89. 10.1136\/annrheumdis-2018-214436","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027230","article-title":"Association between clinical phenotypes of dermatomyositis and polymyositis with myositis-specific antibodies and overlap systemic autoimmune diseases","volume":"100","author":"Chiang HL","year":"2021","unstructured":"Chiang HL, Tung CH, Huang KY, et al.. Association between clinical phenotypes of dermatomyositis and polymyositis with myositis-specific antibodies and overlap systemic autoimmune diseases. Medicine (Baltimore). 2021, 100:e27230. 10.1097\/MD.0000000000027230","journal-title":"Medicine (Baltimore)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7875","article-title":"Assessment of optimal screening tests for the detection of an inflammatory myositis-associated interstitial lung disease","volume":"12","author":"Castillo S","year":"2020","unstructured":"Castillo S, Forbes B, Chen J, Hamblin MJ. Assessment of optimal screening tests for the detection of an inflammatory myositis-associated interstitial lung disease. Cureus. 2020, 12:e7875. 10.7759\/cureus.7875","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.023","article-title":"Association of antinuclear antibody status with clinical features and malignancy risk in adult-onset dermatomyositis","volume":"80","author":"Hoesly PM","year":"2019","unstructured":"Hoesly PM, Sluzevich JC, Jambusaria-Pahlajani A, Lesser ER, Heckman MG, Abril A. Association of antinuclear antibody status with clinical features and malignancy risk in adult-onset dermatomyositis. J Am Acad Dermatol. 2019, 80:1364-70. 10.1016\/j.jaad.2018.11.023","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-017-8974-3","article-title":"Reflex testing of speckled cytoplasmic patterns observed in routine ANA HEp-2 indirect immunofluorescence with a multiplex anti-synthetase dot-blot assay: a multicentric pilot study","volume":"66","author":"Infantino M","year":"2018","unstructured":"Infantino M, Palterer B, Biagiotti R, et al.. Reflex testing of speckled cytoplasmic patterns observed in routine ANA HEp-2 indirect immunofluorescence with a multiplex anti-synthetase dot-blot assay: a multicentric pilot study. Immunol Res. 2018, 66:74-8. 10.1007\/s12026-017-8974-3","journal-title":"Immunol Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac198","article-title":"Statin-associated immune-mediated necrotizing myositis in Native Americans","volume":"61","author":"Muruganandam M","year":"2022","unstructured":"Muruganandam M, Iqbal A, Akpan EB, et al.. Statin-associated immune-mediated necrotizing myositis in Native Americans. Rheumatology (Oxford). 2022, 61:4855-62. 10.1093\/rheumatology\/keac198","journal-title":"Rheumatology (Oxford)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg IE","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, et al.. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017, 76:1955-64. 10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05013-7","article-title":"A prospective cross-sectional study of serum IL-17A in antisynthetase syndrome","volume":"39","author":"Behrens Pinto GL","year":"2020","unstructured":"Behrens Pinto GL, Carboni RC, de Souza FH, Shinjo SK. A prospective cross-sectional study of serum IL-17A in antisynthetase syndrome. Clin Rheumatol. 2020, 39:2763-71. 10.1007\/s10067-020-05013-7","journal-title":"Clin Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach Y","year":"2018","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. Neuromuscul Disord. 2018, 28:87-99. 10.1016\/j.nmd.2017.09.016","journal-title":"Neuromuscul Disord"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq270","article-title":"Aids to the investigation of peripheral nerve injuries. Medical Research Council: Nerve Injuries Research Committee. His Majesty's Stationery Office: 1942; pp. 48 (iii) and 74 figures and 7 diagrams; with aids to the examination of the peripheral nervous system. By Michael O'Brien for the Guarantors of Brain. Saunders Elsevier: 2010; pp. [8] 64 and 94 Figures","volume":"133","author":"Compston A","year":"2010","unstructured":"Compston A. Aids to the investigation of peripheral nerve injuries. Medical Research Council: Nerve Injuries Research Committee. His Majesty's Stationery Office: 1942; pp. 48 (iii) and 74 figures and 7 diagrams; with aids to the examination of the peripheral nervous system. By Michael O'Brien for the Guarantors of Brain. Saunders Elsevier: 2010; pp. [8] 64 and 94 Figures. Brain. 2010, 133:2838-44. 10.1093\/brain\/awq270","journal-title":"Brain"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.103013","article-title":"An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management","volume":"21","author":"Decker P","year":"2022","unstructured":"Decker P, Moulinet T, Pontille F, Cravat M, De Carvalho Bittencourt M, Jaussaud R. An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management. Autoimmun Rev. 2022, 21:103013. 10.1016\/j.autrev.2021.103013","journal-title":"Autoimmun Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-024-03382-x","article-title":"Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy","volume":"26","author":"Weng CT","year":"2024","unstructured":"Weng CT, Huang TH, Wu CH, Sun YT. Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy. Arthritis Res Ther. 2024, 26:152. 10.1186\/s13075-024-03382-x","journal-title":"Arthritis Res Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-025-00441-y","article-title":"Patients with anti-PM\/Scl-positive and idiopathic inflammatory myopathy resemble anti-synthetase syndrome","volume":"65","author":"Barbosa RD","year":"2025","unstructured":"Barbosa RD, Shinjo SK. Patients with anti-PM\/Scl-positive and idiopathic inflammatory myopathy resemble anti-synthetase syndrome. Adv Rheumatol. 2025, 65:9. 10.1186\/s42358-025-00441-y","journal-title":"Adv Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.04.012","article-title":"The phenotype of myositis patients with anti-Ku autoantibodies","volume":"51","author":"Casal-Dominguez M","year":"2021","unstructured":"Casal-Dominguez M, Pinal-Fernandez I, Derfoul A, et al.. The phenotype of myositis patients with anti-Ku autoantibodies. Semin Arthritis Rheum. 2021, 51:728-34. 10.1016\/j.semarthrit.2021.04.012","journal-title":"Semin Arthritis Rheum"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14691","article-title":"Clinically amyopathic dermatomyositis: Clinical, laboratory, and histopathological features","volume":"51","author":"Wang X","year":"2024","unstructured":"Wang X, De Moll E, Koschitzky M, Shihab N, Khattri S, Phelps R. Clinically amyopathic dermatomyositis: Clinical, laboratory, and histopathological features. J Cutan Pathol. 2024, 51:799-806. 10.1111\/cup.14691","journal-title":"J Cutan Pathol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-475","article-title":"Narrative review of autoantibodies in idiopathic inflammatory myopathies","volume":"11","author":"Liu Y","year":"2023","unstructured":"Liu Y, Zheng Y, Hao H, Yuan Y. Narrative review of autoantibodies in idiopathic inflammatory myopathies. Ann Transl Med. 2023, 11:291. 10.21037\/atm-21-475","journal-title":"Ann Transl Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(25)00233-9","article-title":"Advances in the classification and management of idiopathic inflammatory myopathies","volume":"24","author":"Raaphorst J","year":"2025","unstructured":"Raaphorst J, van der Kooi AJ, Mecoli CA, et al.. Advances in the classification and management of idiopathic inflammatory myopathies. Lancet Neurol. 2025, 24:776-88. 10.1016\/S1474-4422(25)00233-9","journal-title":"Lancet Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282X-ANP-2022-S131","article-title":"Inflammatory myopathies: an update for neurologists","volume":"80","author":"Silva AM","year":"2022","unstructured":"Silva AM, Campos ED, Zanoteli E. Inflammatory myopathies: an update for neurologists. Arq Neuropsiquiatr. 2022, 80:238-48. 10.1590\/0004-282X-ANP-2022-S131","journal-title":"Arq Neuropsiquiatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach Y","year":"2020","unstructured":"Allenbach Y, Benveniste O, Stenzel W, Boyer O. Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol. 2020, 16:689-701. 10.1038\/s41584-020-00515-9","journal-title":"Nat Rev Rheumatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217096","article-title":"Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies","volume":"81","author":"Yang H","year":"2022","unstructured":"Yang H, Li W, Tian X, Wang G, Shu X, Peng Q, Lu X. Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies. Ann Rheum Dis. 2022, 81:e48. 10.1136\/annrheumdis-2020-217096","journal-title":"Ann Rheum Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.05.003","article-title":"Integrated diagnosis project for inflammatory myopathies: an association between autoantibodies and muscle pathology","volume":"16","author":"Suzuki S","year":"2017","unstructured":"Suzuki S, Uruha A, Suzuki N, Nishino I. Integrated diagnosis project for inflammatory myopathies: an association between autoantibodies and muscle pathology. Autoimmun Rev. 2017, 16:693-700. 10.1016\/j.autrev.2017.05.003","journal-title":"Autoimmun Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103962","article-title":"Autoantibody internalization in myositis skeletal muscle: emerging evidence, mechanistic insights, and therapeutic relevance","author":"Kirou RA","year":"2025","unstructured":"Kirou RA, Pinal-Fernandez I, Mammen AL. Autoantibody internalization in myositis skeletal muscle: emerging evidence, mechanistic insights, and therapeutic relevance. Autoimmun Rev. 2025, 103962. 10.1016\/j.autrev.2025.103962","journal-title":"Autoimmun Rev"},{"key":"ref29","article-title":"The Classification Criteria for Anti-Synthetase Syndrome (Class) project","volume":"76","year":"2024","unstructured":"The Classification Criteria for Anti-Synthetase Syndrome (Class) project. Arthritis Rheumatol. 2024, 76.","journal-title":"Arthritis Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/453211-characterization-of-antinuclear-myositis-specific-and-myositis-associated-antibodies-in-a-large-sample-of-patients-with-idiopathic-inflammatory-myopathies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T18:20:13Z","timestamp":1772475613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/453211-characterization-of-antinuclear-myositis-specific-and-myositis-associated-antibodies-in-a-large-sample-of-patients-with-idiopathic-inflammatory-myopathies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.104553","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,2]]}}}